41.87% | % of shares held by all insiders |
30.23% | % of shares held by institutions |
52.01% | % of float held by institutions |
53 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BVF Inc. | 14,571,236 | 30 Dec 2023 | 14.73% | 34,242,403 |
Avidity Partners Management, LP | 4,469,080 | 30 Dec 2023 | 4.52% | 10,502,337 |
Blackrock Inc. | 2,418,020 | 30 Dec 2023 | 2.44% | 5,682,346 |
Redmile Group, LLC | 2,000,000 | 30 Dec 2023 | 2.02% | 4,699,999 |
Morgan Stanley | 1,757,240 | 30 Dec 2023 | 1.78% | 4,129,513 |
Platinum Investment Management Ltd | 1,515,585 | 30 Dec 2023 | 1.53% | 3,561,624 |
Wells Fargo & Company | 1,148,691 | 30 Dec 2023 | 1.16% | 2,699,423 |
Stempoint Capital LP | 434,588 | 30 Dec 2023 | 0.44% | 1,021,281 |
Renaissance Technologies, LLC | 417,579 | 30 Dec 2023 | 0.42% | 981,310 |
Deutsche Bank Aktiengesellschaft | 253,375 | 30 Dec 2023 | 0.26% | 595,431 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BlackRock Health Sciences Term Trust | 752,390 | 30 Dec 2023 | 0.76% | 1,768,116 |
iShares Biotechnology ETF | 429,040 | 28 Feb 2024 | 0.43% | 1,008,243 |
Blackrock Health Sciences Trust | 78,180 | 30 Dec 2023 | 0.08% | 183,722 |
Pacific Select Fund-Health Sciences Portfolio | 53,150 | 30 Dec 2023 | 0.05% | 124,902 |
Fidelity NASDAQ Composite Index Fund | 45,869 | 30 Jan 2024 | 0.05% | 107,792 |
Fidelity Select Portfolios - Biotechnology | 27,202 | 30 Jan 2024 | 0.03% | 63,924 |
DFA U.S. Vector Equity Portfolio | 15,821 | 30 Jan 2024 | 0.02% | 37,179 |
DFA U.S. Micro Cap Series | 10,530 | 30 Jan 2024 | 0.01% | 24,745 |
DFA U.S. Core Equity 2 Portfolio | 8,197 | 30 Jan 2024 | 0.01% | 19,262 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 5,991 | 28 Feb 2024 | 0.01% | 14,078 |